173 related articles for article (PubMed ID: 8162935)
1. Quantitative comparison between 99mTc-HMPAO and 99mTc-ECD: measurement of arterial input and brain retention.
Pupi A; Castagnoli A; De Cristofaro MT; Bacciottini L; Petti AR
Eur J Nucl Med; 1994 Feb; 21(2):124-30. PubMed ID: 8162935
[TBL] [Abstract][Full Text] [Related]
2. A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropylene amine oxime.
Matsuda H; Yagishita A; Tsuji S; Hisada K
Eur J Nucl Med; 1995 Jul; 22(7):633-7. PubMed ID: 7498224
[TBL] [Abstract][Full Text] [Related]
3. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults.
Inoue K; Nakagawa M; Goto R; Kinomura S; Sato T; Sato K; Fukuda H
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088
[TBL] [Abstract][Full Text] [Related]
4. Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease.
Donnemiller E; Heilmann J; Wenning GK; Berger W; Decristoforo C; Moncayo R; Poewe W; Ransmayr G
Eur J Nucl Med; 1997 Mar; 24(3):320-5. PubMed ID: 9143472
[TBL] [Abstract][Full Text] [Related]
5. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB
J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168
[TBL] [Abstract][Full Text] [Related]
6. Different uptake of 99mTc-ECD adn 99mTc-HMPAO in the same brains: analysis by statistical parametric mapping.
Hyun Y; Lee JS; Rha JH; Lee IK; Ha CK; Lee DS
Eur J Nucl Med; 2001 Feb; 28(2):191-7. PubMed ID: 11303889
[TBL] [Abstract][Full Text] [Related]
7. An alternative approach to estimation of the brain perfusion index for measurement of cerebral blood flow using technetium-99m compounds.
Murase K; Inoue T; Fujioka H; Ishimaru Y; Akamune A; Yamamoto Y; Mochizuki T; Ikezoe J
Eur J Nucl Med; 1999 Oct; 26(10):1333-9. PubMed ID: 10541833
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of cerebral vasoreactivity to acetazolamide in normal volunteer among 123I-IMP, 99mTc-ECD and 99mTc-HMPAO].
Makino K; Masuda Y; Gotoh S
Kaku Igaku; 1996 May; 33(5):551-5. PubMed ID: 8699624
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-HMPAO and 99mTc-ECD perform differently in typically hypoperfused areas in Alzheimer's disease.
Koulibaly PM; Nobili F; Migneco O; Vitali P; Robert PH; Girtler N; Darcourt J; Rodriguez G
Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1009-13. PubMed ID: 12750851
[TBL] [Abstract][Full Text] [Related]
10. Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: a comparison.
Asenbaum S; Brücke T; Pirker W; Pietrzyk U; Podreka I
J Nucl Med; 1998 Apr; 39(4):613-8. PubMed ID: 9544665
[TBL] [Abstract][Full Text] [Related]
11. Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects.
Léveillé J; Demonceau G; Walovitch RC
J Nucl Med; 1992 Apr; 33(4):480-4. PubMed ID: 1552328
[TBL] [Abstract][Full Text] [Related]
12. Comparative SPECT study of stroke using Tc-99m ECD, I-123 IMP, and Tc-99m HMPAO.
Matsuda H; Li YM; Higashi S; Sumiya H; Tsuji S; Kinuya K; Hisada K; Yamashita J
Clin Nucl Med; 1993 Sep; 18(9):754-8. PubMed ID: 8403717
[TBL] [Abstract][Full Text] [Related]
13. Intra-individual differences between technetium-99m-HMPAO and technetium-99m-ECD in the normal medial temporal lobe.
Oku N; Matsumoto M; Hashikawa K; Moriwaki H; Ishida M; Seike Y; Terakawa H; Watanabe Y; Uehara T; Nishimura T
J Nucl Med; 1997 Jul; 38(7):1109-11. PubMed ID: 9225799
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of technetium 99m cyclobutylpropylene amine oxime as a potential brain perfusion imaging agent for SPET.
Bacciottini L; Lunghi F; Pupi A; Bonino C; Formiconi AR; De Cristofaro MT; Petti AR; Meldolesi U
Eur J Nucl Med; 1990; 17(5):242-7. PubMed ID: 2083559
[TBL] [Abstract][Full Text] [Related]
15. Combination of early and delayed SPET imaging using technetium-99m ethyl cysteinate dimer immediately after local intra-arterial thrombolysis.
Ogasawara K; Ogawa A; Konno H; Shibanai K; Doi M; Kuroda K; Yoshimoto T
Eur J Nucl Med; 2001 Apr; 28(4):498-505. PubMed ID: 11357501
[TBL] [Abstract][Full Text] [Related]
16. Database of normal human cerebral blood flow measured by SPECT: I. Comparison between I-123-IMP, Tc-99m-HMPAO, and Tc-99m-ECD as referred with O-15 labeled water PET and voxel-based morphometry.
Ito H; Inoue K; Goto R; Kinomura S; Taki Y; Okada K; Sato K; Sato T; Kanno I; Fukuda H
Ann Nucl Med; 2006 Feb; 20(2):131-8. PubMed ID: 16615422
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of 99mTc-ECD and 99mTc-HMPAO for peri-ictal SPECT: qualitative and quantitative analysis.
O'Brien TJ; Brinkmann BH; Mullan BP; So EL; Hauser MF; O'Connor MK; Hung J; Jack CR
J Neurol Neurosurg Psychiatry; 1999 Mar; 66(3):331-9. PubMed ID: 10084532
[TBL] [Abstract][Full Text] [Related]
18. SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD.
Koyama M; Kawashima R; Ito H; Ono S; Sato K; Goto R; Kinomura S; Yoshioka S; Sato T; Fukuda H
J Nucl Med; 1997 Apr; 38(4):587-92. PubMed ID: 9098207
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-D,L-hexamethylene-propyleneamine oxime (99mTc-HMPAO): basic kinetic studies of a tracer of cerebral blood flow.
Andersen AR
Cerebrovasc Brain Metab Rev; 1989; 1(4):288-318. PubMed ID: 2701656
[TBL] [Abstract][Full Text] [Related]
20. An analysis of the arterial input curve for technetium-99m-HMPAO: quantification of rCBF using single-photon emission computed tomography.
Pupi A; De Cristofaro MT; Bacciottini L; Antoniucci D; Formiconi AR; Mascalchi M; Meldolesi U
J Nucl Med; 1991 Aug; 32(8):1501-6. PubMed ID: 1869968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
